Global

‡ In these countries please contact our distributor

RENASYS TOUCH

This information is intended for HCPs in the US.
Please consult your local Smith + Nephew representative for further details on products available in your market.  

 

RENASYS TOUCH tNPWT

Easy-to-use, clinically effective NPWT for acute care1,2 

The RENASYS TOUCH Negative Pressure Wound Therapy System is designed to cut through the complexity of traditional NPWT, and be:

Clinically effective for complex wounds with proven clinical outcomes1 in the reduction of wound area and volume, and comparable performance to V.A.C.™2
Powerfully simple as part of our intuitive platform for all care settings

 

Suitable for a wide range of indicated wound types1,3 

 

 

Simplified delivery of advanced therapy

For patients

  1. Small, lightweight and portable – supporting patients’ lifestyles during therapy3-5
  2. Adjustable compression rate – helps maximize patient experience based on wound conditions and pain tolerance1
  3. Soft Port technology – to enhance patient comfort - even on difficult-to-dress areas – and may help reduce the need for bridging6

For clinicians

Easy-to-select therapy – using the intuitive, user-friendly touchscreen, clinicians found therapy selection very easy in 99% of applications1

Easy to set up – 97% of clinicians found the RENASYS TOUCH System very easy to set up3

Visual leakage gauge – easy location and resolution of air leaks to support responsive clinical intervention

Onscreen guidance and troubleshooting – easy-to-use guidance7 and troubleshooting supports device operation1 

For administration professionals

Tailored business models – working closely with you to design business models around your needs, enabling versatililty in managing budgets

Reduced complexity – a one-system platform and versatile consumables means fewer SKUs to manage, facilitating efficient inventory management and stock replenishment

How to use RENASYS TOUCH tNPWT

Watch: Troubleshooting
Watch: Canister installation
Watch
: Foam application
Watch: Gauze application
Watch
: Ab kit application

For additional guidance, please refer to the clinical resources page.

Demonstrated clinically effective on complex wounds

Clinical evidence has shown that RENASYS TOUCH tNPWT achieved (versus baseline):

  • Statistically significant 55% wound area reduction*3
  • Statistically significant 80% wound volume reduction*3
  • Statistically significant 20% improvement in the amount of healthy viable tissue*3

Watch: the performance of continuous and intermittent therapy with RENASYS tNPWT


 

OneNPWT portfolio – simple just got simpler

One compelling solution to meet your negative pressure wound therapy needs at every stage of the wound care journey.1,8-13

For additional guidance on product selection, visit OneNPWT


Ordering information and support

For further information and guidance, please contact us

For ordering information (RENASYS GO), contact your local Rotech® Healthcare Inc sales representative

For system availability (RENASYS GO), consult the WoundExpert® electronic health records

Helping you get CLOSER TO ZERO delay in wound healing.1 

 

Important Safety Information

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

The PICO 7 pump contains a MAGNET. Keep the PICO 7 pump at least 4 inches (10 cm) away from other medical devices at all times. Failure to do so can cause the other medical devices to fail which can result in serious harm including death. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. The risk information provided herein is not comprehensive. For full product and safety information, please see the Instructions for Use.

*Randomized clinical trial over a 4-week study period. Chronic wounds (n=71), sub- acute wounds (n=35), acute wounds (n=36). Wound area reduction: p<0.001. Wound volume: p<0.001. Improvement in healthy viable tissue: p<0.001.

All trademarks acknowledged.

 

References:

  1. Forlee M, Richardson J, Rossington A, Cockwill J, Smith J. An interim analysis of device functionality and usability of RENASYS™ TOUCH – a new portable Negative Pressure Wound Therapy (NPWT) system. Paper presented at: Wounds UK; 2016; Harrogate, UK.
  2. Hurd T, Rossington A, Trueman P, Smith J. A Retrospective Comparison of the Performance of Two Negative Pressure Wound Therapy Systems in the Management of Wounds of Mixed Etiology. Advances in Wound Care. 2017;6(1):33–37.
  3. Forlee M, van Zyl L, Louw V, Nel J, Fourie N, Hartley R. A randomised controlled trial to compare the clinical efficacy and acceptability of adjustable intermittent and continuous Negative Pressure Wound Therapy (NPWT) in a new portable NPWT system. Paper presented at: EWMA; 2018; Krakow, Poland.
  4. Smith and Nephew 2016. Smith & Nephew’s RENASYS™ Touch Device Features of Mobility and Modesty. DS/16/140/R. Smith & Nephew 2016.
  5. Smith and Nephew’s RENASYS™ Touch Device – User Experience. DS/16/141/R.
  6. Smith & Nephew 2012.A prospective, open, non-comparative, multi-centre study to evaluate the functionality and device performance of a new Negative Pressure Wound Therapy (NPWT) suction port (RENASYS _Soft Port) in the management of acute, sub-acute and chronic wounds CSR/CT/US/11/01.
  7. Bannow, Tara. Ballooning costs, government mandates were hospitals’ biggest challenges in 2018. Modern Healthcare. January 17, 2019.
  8. Smith & Nephew January 2018. Outcomes following PICO compared to conventional dressings when used prophylactically on closed surgical incisions: systematic literature review and meta-analysis. Internal Report. EO/AWM/PICO/004/v1.
  9. Hurd T, Chadwick P, Cote J, et al. Impact of gauze-based NPWT on the patient and nursing experience in the treatment of challenging wounds. International Wound Journal. 2010;7(6):448-455.
  10. Kantar Health market research report, November 2018.
  11. O’leary DP, Peirce C, Anglim B, et al.Prophylactic Negative Pressure Dressing Use in Closed Laparotomy Wounds Following Abdominal Operations: A Randomized, Controlled, Open-label Trial: The P.I.C.O. Trial. Ann Surg. 2017;265(6):1082-1086.
  12. Selvaggi F, Pellino G, Sciaudone G, et al.New Advances in Negative Pressure Wound Therapy (NPWT) for Surgical Wounds of Patients Affected with Crohn’s Disease. Surgical Technology International. 2014;24:83-89.
  13. Karlakki SL, Hamad AK, Whittall C, et al.Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial. Bone Joint Res. 2016;5(8):328-337.
  14. Dowsett C, et al. Use of PICO to improve clinical and economic outcomes in hard-to-heal wounds. Wounds International. 2017;8, p53–58.
  15. Kirsner R, Dove C, Reyzelman A, Vayser D, Jaimes H. A prospective, randomized, controlled clinical trial on the efficacy of a single-use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of chronic ulcers of the lower extremities. Wound Repair Regen. 2019 Sept;27(5):519-529.

 

Important Safety Information

 

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

How does RENASYS compare to V.A.C.™?

Find out more

RENASYS◊  GO
Post-Acute NPWT Solution in the United States

Order your RENASYS GO pump in the US through Rotech Healthcare, Inc.

Download now

Intended for HCPs in the US only